Laura Deming is the CEO and co-founder of Until and a partner at The Longevity Fund, where they focus on investments in companies targeting the aging process to treat disease. Starting their journey in biogerontology at the age of 12, Laura participated in multiple research roles, including at UCSF and MIT, before becoming a Thiel Fellow at 17. Currently, they are dedicated to advancing scientific breakthroughs in longevity and age-associated therapies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices